VRCA

2.7405.03%
JJ

John J. Kirby

Interim Chief Financial Officer

Mr. John J. Kirby, CPA, is Senior VP, president, Virtua Mount Holly & Willingboro hospitals of Virtua Health, Inc. He Interim Chief Financial Officer of Verrica Pharmaceuticals Inc. from November 5, 2024. Mr. Kirby served as Chief Financial Officer at Aceragen, Inc. (formerly known as Idera Pharmaceuticals, Inc.) since July 23, 2019 until April 05, 2023 and was Senior Vice President since July 1, 2019 until 2022 and served as Principal Financial Officer and Principal Accounting Officer at Aceragen, Inc. (formerly known as Idera Pharmaceuticals, Inc.) since October 31, 2018 until July 23, 2019. He joined the Aceragen, Inc. (formerly known as Idera Pharmaceuticals, Inc.) in 2015. He was a Vice President of Finance of Aceragen, Inc. (formerly known as Idera Pharmaceuticals, Inc.) from July 2018 to July 2019 and joined as its Vice President of Corporate Accounting on November 30, 2015. Mr. Kirby served as Assistant Controller at Endo Pharmaceuticals from November 2014 to October 2015. Prior to Endo, he served as the Chief Accounting Officer, Controller and Vice President at ViroPharma Inc. from August 2012 to January 24, 2014 and also served as its Corporate Controller. Previously, he was with AstraZeneca Pharmaceuticals from 2010 to 2012 where he held positions of increasing responsibility, as the Regional Audit Director - Americas. Mr. Kirby was with KPMG LLP, in their Healthcare and Life Science Practice and served as a Regional Audit Director at AstraZeneca Pharmaceuticals L.P, where he held positions of increasing responsibility, as Senior Manager. While at KPMG, he was responsible for planning and directing the audit process at various public and private company clients. He received his Bachelor of Science degree in Accounting from Villanova University and is a licensed Certified Public Accountant in the Commonwealth of Pennsylvania.

Positions